The lack of compelling evidence that tau reduction causes derangements of microtubules or alterations in microtubule dynamics that affect neuronal function or integrity raises questions about earlier assumptions regarding the pathophysiology of AD and other tauopathies – particularly with regard to the primary/pivotal role of tau's detachment from microtubules and subsequent self‐aggregation. This evidence concerns the gene MAPT and Alzheimer disease.